AGP Executive Report
Last update: 11 hours agoHemp Rules: U.S. hemp businesses say a congressional deadline extension offers only temporary relief: federal restrictions due in December could still push many CBD and THC products off shelves, leaving small firms unsure how to plan. Product Safety: Recent reports of children consuming hemp or CBD gummies—including three students hospitalized after eating CBD gummies at school—highlight the need for secure storage and clear labeling. Health Research: A Cochrane review found insufficient support for medical cannabis as an insomnia treatment, tempering claims about its use for sleep. Global Industry: MediPharm Labs reported its first shipment of a CBD metered-dose inhaler to Panama, extending its regulated medical-cannabis business internationally.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.